People deserve
better answers.


Innovative solutions that empower researchers, from ALS to fragile X syndrome.

Learn more about our Genetics portfolio

Solving complex molecular challenges, from leukemia to solid tumors.

Learn more about our Oncology portfolio
MolecularDx Controls

The gold standard for molecular quality controls.

Learn more about our custom offerings

Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis

CFTR testing kit with streamlined workflow delivers reliable results in less than five hours

Learn More

Asuragen Announces Launch of AmplideX® PCR/CE SMN1/2 Plus Kit

The AmplideX® PCR/CE SMN1/2 Plus Kit is a clinical research tool providing the most comprehensive analysis of SMN1 and SMN2 currently available from a commercial kit.

Learn more

Asuragen Expands Genetic Portfolio with Launch of AmplideX® PCR/CE HTT Kit

The AmplideX® PCR/CE HTT Kit is a simple, robust, and reliable test for the detection of CAG trinucleotide repeats within the HTT gene, aberrations which are associated with the development of Huntington’s Disease (HD).

Read more

Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control

Asuragen, Inc has developed an Armored RNA Quant® SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic.

Learn more about our custom control offerings

The Latest from Asuragen

Fast & Easy FMR1 Analysis with AmplideX PCR/CE Reporter Software
Back To